PAST PROJECTS

		PATHCO Pathogen Co-infection: HIV-1, Tuberculosis, Malaria and hepatitis C virus.
		EUMBRELLA EU-funded cooperative research projects in the field of Chronic inflammatory/autoimmune diseases.
		TIMER TargetIng novel MEchanisms of Resolution in inflammation.
		TARKINAID Targeting Src-family tyrosine kinases in chronic autoimmune and inflammatory diseases.
		PANACREAS Integrating chemical approaches to treat pancreatic cancer: making new leads for a cure.
		ONESTUDY A Unified Approach to Evaluating Cellular Immunotherapy in Solid Organ Transplantation.
		ALLFUN Fungi in the setting of inflammation, allergy and autoimmune diseases: Translating basic science into clinical practices.
		EIMID European Institute of Microbiology and Infectious Diseases.
		START-T-REK Set up and comparison of multiple stem cell approaches for kidney repair.
		DEVANI Design of a vaccine to immunize neonates against GBS infections through a durable maternal immune response.
		EUROPRISE European Vaccines and Microbicides Enterprise. Network of excellence.
		HEPACIVAC New preventative and therapeutic Hepatitis C vaccines: from pre-clinical to phase 1.
		CORMRA Development of carbon monoxide releasing molecules for the treatment of rheumatoid arthritis.
		EXERA Development of 3D in vitro models of estrogen-reporter mouse tissues for the pharmaco-toxicological analysis of nuclear receptors-interacting compounds (NR-ICs).
		FLUINNATE Innate immunity in influenza virus infection of mammalian airways.
		INNOCHEM Innovative Chemokine-based Therapeutic Strategies for Autoimmunity and Chronic Inflammation.
		ADIT Design of small molecule therapeutics for the treatment of Alzheimer Disease based on the discovery of Innovative drug Targets.
		MUVAPRED MUcosal VAccines for Poverty RElated Diseases.
		REBAVAC Novel opportunities to develop VACcines to control antibiotic REsistant BActeria: from the trials back to the laboratory.
		SARSVAC Immunoprevention and immunotherapy of SARS infection.
		EASYRING Develop and validate novel non-invasive methods for the detection of known and new biomarkers of EDs directly in the mucus of aquatic species.
		GLYCIDIC SCAFFOLDS New carbohydrate-derived scaffolds for the generation of bioactive libraries.
		TFSS Type IV secretion systems as targets for anti-infectious therapies.
		INNAMORA Novel Strategies of Mucosal Immunisation through Exploitation of Mechanisms of Innate Immunity in Pathogen-Host Interaction. Siena, Nov. 6-10, 2002.
		MEMOVAX Immunological memory and vaccination.
		APOCLEAR Novel therapeutic strategies for the treatment of human autoimmune diseases.
		MUC IMM European research groups excellent in mucosal immunology and vaccines were here integrated into a cluster.
		MUCADY Mucosal administration of antigens is a global priority and is recommended by the 5th Framework Programme of the European Union.

Legal activities

Negotations
Consortium Agreements
Intellectual Property Protection Dissemination activities

Project Web Sites
Public awareness of projects
Meetings and events

Training activities

Organization and co-ordination of training in scientific issues and
complementary skills

back